Clinical trial
Dexmedetomidine as an Adjuvant to Bupivacaine in Bilateral Pectoral Nerve Blocks for Postoperative Pain Control After Cardiac Surgeries: A Randomized Controlled Trial
NCT06453681 is registered in ClinicalTrials.gov with Kasr El Aini Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dexmedetomidine as an Adjuvant to Bupivacaine in Bilateral Pectoral Nerve Blocks for Postoperative Pain Control After Cardiac Surgeries: A Randomized Controlled Trial
- Lead sponsor
- Kasr El Aini Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 1, 2024
- Completion date
- May 2, 2025
- Enrollment
- 60 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
post operative pain